EQL Pharma AB
Develops and sells cost-efficient niche generic medicines for the Nordic healthcare market.
EQL | ST
Overview
Corporate Details
- ISIN(s):
- SE0005497732
- LEI:
- 549300Q8B2D2AE8GCW21
- Country:
- Sweden
- Address:
- Stortorget 1, 222 23 Lund
- Website:
- https://eqlpharma.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
EQL Pharma is a pharmaceutical company that develops, sells, and markets cost-efficient medicines, primarily for the Nordic markets. The company's strategy focuses on niche generics—medicines with expired patents and limited competition—to ensure value and accessibility. Its core operational areas include Generics, Speciality Pharma, and Parallel Import. EQL Pharma conducts extensive development activities in collaboration with international partners in Asia, Europe, and India, serving pharmacies and hospitals with a portfolio of unique and high-quality medicines.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-06 15:08 |
Board/Management Information
EQL Pharma i process att rekrytera ny Chief Commercial Officer (CCO)
|
Swedish | 332.6 KB | ||
| 2025-10-06 15:08 |
Board/Management Information
EQL Pharma in process of recruiting new Chief Commercial Officer (CCO)
|
English | 172.7 KB | ||
| 2025-09-30 10:00 |
Declaration of Voting Results & Voting Rights Announcements
Ändring av antalet aktier och röster i EQL Pharma AB
|
Swedish | 167.4 KB | ||
| 2025-09-30 10:00 |
Declaration of Voting Results & Voting Rights Announcements
Change in number of shares and votes in EQL Pharma AB
|
English | 167.5 KB | ||
| 2025-09-22 22:35 |
Earnings Release
Delivery delays mean that the second quarter and thus the full year 2025/26 wil…
|
English | 224.7 KB | ||
| 2025-09-22 22:35 |
Earnings Release
Leveransförseningar gör att andra kvartalet och därmed helåret 2025/26 blir sva…
|
Swedish | 150.7 KB | ||
| 2025-08-21 18:00 |
Post-Annual General Meeting Information
Kommuniké från årsstämma i EQL Pharma AB den 21 augusti 2025
|
Swedish | 258.1 KB | ||
| 2025-08-21 18:00 |
Post-Annual General Meeting Information
Bulletin from the annual general meeting in EQL Pharma AB on 21 August 2025
|
English | 259.5 KB | ||
| 2025-08-18 11:00 |
Board/Management Information
Valberedningens förslag inför årsstämman i EQL Pharma AB
|
Swedish | 322.2 KB | ||
| 2025-08-18 11:00 |
Board/Management Information
The Nomination Committee’s proposal for the annual general meeting in EQL Pharm…
|
English | 321.4 KB | ||
| 2025-08-08 07:00 |
Earnings Release
|
Swedish | 1.2 MB | ||
| 2025-08-08 07:00 |
Quarterly Report
|
English | 1.3 MB | ||
| 2025-07-22 10:00 |
Pre-Annual General Meeting Information
Kallelse till årsstämma i EQL Pharma AB
|
Swedish | 281.5 KB | ||
| 2025-07-22 10:00 |
Pre-Annual General Meeting Information
Notice of annual general meeting in EQL Pharma AB
|
English | 287.5 KB | ||
| 2025-05-08 07:00 |
Earnings Release
|
Swedish | 1.3 MB |
Automate Your Workflow. Get a real-time feed of all EQL Pharma AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for EQL Pharma AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-17 | christer fåhraeus | Other | Sell | 100,000 | 8,620,000.00 SEK |
